Biallelic mutations in VSX2 are thought to account for 2% of isolated microphthalmia, and were identified in 1.5% of all MAC (microphthalmia, anophthalmia and coloboma) cases in a screening of >880 samples [9,12]. The gene discussed is VSX2; the disease is coloboma.